Families say it's 'completely frustrating' that children with Duchenne Muscular Dystrophy are being denied access to free ...

Dyne anticipates filing a Biologics License Application (BLA) submission for US accelerated approval in early 2026.

Dyne Therapeutics (DYN) announced that the European Commission has granted orphan drug designation for DYNE-251 for the treatment of Duchenne ...

The orphan drug designation is particularly noteworthy as it can provide Dyne with a range of benefits, including reduced regulatory fees, assistance with clinical protocols, eligibility for research ...

The Jaffa Shriners’ DuBois Area Shrine Club continues to support a wheelchair program that provides essential equipment to ...

Key treatments for Alzheimer’s, rare cancers, and infectious diseases are under review, with new vaccines and therapies like ...

The co-owner, Chad Day, has been a part of the fundraising efforts for the six-year-old with Duchenne muscular dystrophy.

ABEL Motorsports driver Callum Hedge (photo) is trying to raise awareness and funds to combat muscular dystrophy in his ...

This year's Futures National Conference, hosted by CureDuchenne for the Duchenne and Becker MD communities, is scheduled to ...